Did a Drug Company ‘Buy’ One of This Year’s Nobel Prizes?

Probably not:

Rumors swirl, but a Swedish prosecutor will only confirm a “preliminary investigation” into allegations that pharma giant AstraZeneca fixed the Nobels for financial gain.
————————-
As for the Nobels, as scurrilous as the charges may sound, there is little evidence to support them. First off, AstraZeneca’s ties to the anti-HPV vaccine are tenuous at best: In 2007 it purchased a company called MedImmune, which had developed the viruslike particle (VLP) technology licensed for use in Merck’s Gardasil and GlaxoSmithKline’s Cervarix vaccines — both designed to prevent HPV infection. The technology, however, is not specific to HPV and companies are working to adapt VLPs and similar techniques for a variety of vaccines, including influenza….

Read the rest…

Comments are closed.